OSENI Drug Profile, 2023

OSENI Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899887
Category : Medical
Languages : en
Pages : 98

Get Book Here

Book Description

OSENI Drug Profile, 2023

This report focuses on OSENI and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

OSENI Drug Profile, 2023

OSENI Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899887
Category : Medical
Languages : en
Pages : 98

Get Book Here

Book Description

OSENI Drug Profile, 2023

This report focuses on OSENI and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


NESINA Drug Profile, 2023

NESINA Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899852
Category : Medical
Languages : en
Pages : 100

Get Book Here

Book Description

NESINA Drug Profile, 2023

This report focuses on NESINA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


EDURANT Drug Profile, 2023

EDURANT Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899860
Category : Medical
Languages : en
Pages : 100

Get Book Here

Book Description

EDURANT Drug Profile, 2023

This report focuses on EDURANT and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


KAZANO Drug Profile, 2023

KAZANO Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899844
Category : Medical
Languages : en
Pages : 100

Get Book Here

Book Description

KAZANO Drug Profile, 2023

This report focuses on KAZANO and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers


Stroke Genetics

Stroke Genetics PDF Author: Hugh S. Markus
Publisher:
ISBN: 0198515863
Category : Medical
Languages : en
Pages : 362

Get Book Here

Book Description
Stroke is a major cause of death and the major cause of adult neurological disability in most of the world. Despite its importance on a population basis, research into the genetics of stroke has lagged behind that of many other disorders. However, the situation is now changing. An increasing number of single gene disorders causing stroke are being described, and there is growing evidence that polygenic factors are important in the risk of apparently "sporadic" stroke. Stroke Genetics provides an up-to-date review of the area, suitable for clinicians treating stroke patients, and both clinical and non-clinical researchers in the field of cerebrovascular disease. The full range of monogenic stroke disorders causing cerebrovascular disease, including ischaemic stroke, intracerebral haemorrhage, aneurysms and arteriovenous malformations, are covered. For each, clinical features, diagnosis, and genetics are described. Increasing evidence suggest that genetic factors are also important for the much more common multifactorial stroke; this evidence is reviewed along with the results of genetic studies in this area. Optimal and novel strategies for investigating multifactorial stroke, including the use of intermediate phenotypes such as intima-media thickness and MRI detected small vessel disease are reviewed. The book concludes by describing a practical approach to investigating patients with stroke for underlying genetic disorders. Also included is a list of useful websites.

Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality

Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality PDF Author: Mossialos, Elias
Publisher: McGraw-Hill Education (UK)
ISBN: 0335214657
Category : Education
Languages : en
Pages : 390

Get Book Here

Book Description
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.

Emergency Care for Hazardous Materials Exposure

Emergency Care for Hazardous Materials Exposure PDF Author: Phillip L. Currance
Publisher: Mosby/JEMS
ISBN:
Category : Medical
Languages : en
Pages : 908

Get Book Here

Book Description
This Revised Third Edition is now updated to reflect the 2005 emergency cardiac care guidelines. The need for hazardous materials emergency response has grown with the increased use of chemicals and the threat of terrorism. Designed for both the EMS field provider and first receivers in the hospital setting, this important resource provides field recognition and management guidelines for hazardous materials exposures and associated medical emergencies, including emergency care of exposed and contaminated patients. The 3rd edition has been expanded to provide responders with the information necessary to identify the scene of a terrorist act involving the use of hazardous materials, as well as triage procedures for chemical exposure and the management of a mass casualty incident. A total of 140 guidelines, cross-referenced to indexes, provide essential information on hazard classes and specific chemicals with initial hospital considerations. Descriptions of procedures, scene operations and support, medical surveillance, and suggested emergency equipment. Extensive indexes supply multiple ways to access important information to save critical time in the field. Content is updated to reflect the 2005 emergency cardiac care guidelines. Over 30 new WMD agent guidelines provide concise, consistent information on managing exposure to high-risk substances. Expanded size includes over 150 pages of new material. An expanded index and updated treatment guidelines are included. The treatment protocol section, drug protocol section, and EMS/hazardous materials operating procedures are updated and expanded. How to identify the scene of a terrorist act involving the use of hazardous materials. Information on mass casualty decontamination and crime scene identification will help reader formulate a plan before beginning to work.

Handbook of Property Estimation Methods for Chemicals

Handbook of Property Estimation Methods for Chemicals PDF Author: Donald Mackay
Publisher: CRC Press
ISBN: 1420026283
Category : Science
Languages : en
Pages : 492

Get Book Here

Book Description
A complete restructuring and updating of the classic 1982 Handbook of Chemical Property Estimation Methods (commonly known as "Lyman's Handbook"), the Handbook of Property Estimation Methods for Chemicals: Environmental and Health Sciences reviews and recommends practical methods for estimating environmentally important properties of organic chemic

World Report on Child Injury Prevention

World Report on Child Injury Prevention PDF Author: M. M. Peden
Publisher: World Health Organization
ISBN: 9241563575
Category : Business & Economics
Languages : en
Pages : 233

Get Book Here

Book Description
Child injuries are largely absent from child survival initiatives presently on the global agenda. Through this report, the World Health Organization, the United Nations Children's Fund and many partners have set out to elevate child injury to a priority for the global public health and development communities. It should be seen as a complement to the UN Secretary-General's study on violence against children released in late 2006 (that report addressed violence-related or intentional injuries). Both reports suggest that child injury and violence prevention programs need to be integrated into child survival and other broad strategies focused on improving the lives of children. Evidence demonstrates the dramatic successes in child injury prevention in countries which have made a concerted effort. These results make a case for increasing investments in human resources and institutional capacities. Implementing proven interventions could save more than a thousand children's lives a day.--p. vii.

Reducing Inequalities

Reducing Inequalities PDF Author: Rémi Genevey
Publisher: The Energy and Resources Institute (TERI)
ISBN: 8179935302
Category : Architecture
Languages : en
Pages : 274

Get Book Here

Book Description
The reduction of inequalities within and between countries stands as a policy goal, and deserves to take centre stage in the design of the Sustainable Development Goals agreed during the Rio+20 Summit in 2012.The 2013 edition of A Planet for Life represents a unique international initiative grounded on conceptual and strategic thinking, and – most importantly – empirical experiments, conducted on five continents and touching on multiple realities. This unprecedented collection of works proposes a solid empirical approach, rather than an ideological one, to inform future debate.The case studies collected in this volume demonstrate the complexity of the new systems required to accommodate each country's specific economic, political and cultural realities. These systems combine technical, financial, legal, fiscal and organizational elements with a great deal of applied expertise, and are articulated within a clear, well-understood, growth- and job-generating development strategy.Inequality reduction does not occur by decree; neither does it automatically arise through economic growth, nor through policies that equalize incomes downward via ill conceived fiscal policies. Inequality reduction involves a collaborative effort that must motivate all concerned parties, one that constitutes a genuine political and social innovation, and one that often runs counter to prevailing political and economic forces.